3

OWNERSHIP DOCUMENT

Company: Kalaris Therapeutics, Inc.
Filed: July 30, 2020
Period of Report: July 29, 2020
Accession Number: 0001104659-20-088050

View Document ↗ View on SEC.gov ↗